EMEA-001159-PIP02-12

Key facts

Active substance
Misoprostol
Therapeutic area
Other
Decision number
P/0163/2012
PIP number
EMEA-001159-PIP02-12
Pharmaceutical form(s)
Vaginal delivery system
Condition(s) / indication(s)
Induction of labour
Route(s) of administration
Vaginal use
Contact for public enquiries
Ferring pharmaceuticals A/S
gb3-info@ferring.com 
United Kingdom
+44 1355293166
+44 1355269661
Decision type
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
Compliance procedure number
EMEA-C-001159-PIP02-12
Compliance opinion date
11/10/2012
Compliance outcome
positive

Decision

How useful was this page?

Add your rating